A recent study from Germany shows you can cut your risk without losing weight. People with prediabetes who focused on eating better, moving more, and lowering blood sugar, even if the scales didn’t ...
Toujeo is an injectable insulin medication for the treatment of diabetes (type 1 or type 2) in people who are 6 years old and older. It is a long-acting form of insulin, which allows it to last for a ...
The first 90 days after a type 2 diabetes diagnosis are crucial for managing the condition and reducing heart disease risks. Experts emphasize understanding the body's response to high blood sugar, ...
People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.
Editor's note: Part one of a five-part USA TODAY series revealing why America hasn't solved its long struggle with Type 2 diabetes. For chef Robin Ray, newly married with young stepchildren, the ...
Fortunately, carefully managing your diabetes, reaching certain health targets, and making healthy lifestyle adjustments can all reduce the impact of type 2 diabetes on your lifespan, potentially ...
Considering the fast-paced and stressful lives most people live, Diabetes has become a major lifestyle diseases affecting ...
Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...
Your morning coffee habit might be doing more than just waking you up — it could be providing significant protection against type 2 diabetes while helping manage blood sugar levels if you already have ...
CHICAGO, June 23, 2025 /PRNewswire/ -- New findings from the CATALYST study show that the use of mifepristone resulted in improved blood glucose (blood sugar) control and weight reduction in patients ...
For chef Robin Ray, newly married with young stepchildren, the turning point came when a stabbing chest pain sent her rushing to the emergency room. For Brian Castrucci, the gravity hit when the ER ...
Part 2 of the CATALYST study was a randomized, prospective, placebo-controlled, double-blind multi-center trial designed to assess the safety and efficacy of mifepristone treatment in patients with ...